Related Experiment Video
Updated: Jul 25, 2025
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.8K
Omicron-Induced Immune Thrombocytopenia: A Case Report
Haneen A Toba1, Mohammad Abu-Tineh2, Awni Alshurafa2
1Department of Internal Medicine, Hamad Medical Corporation, Doha, QAT.
Cureus
|June 30, 2023
Summary
Severe thrombocytopenia is a rare complication of coronavirus disease 2019 (COVID-19). This case report details immune thrombocytopenia (ITP) developing after COVID-19, highlighting unusual hematological effects and treatment adjustments.
Area of Science:
- Hematology
- Virology
- Immunology
Background:
- Coronavirus disease 2019 (COVID-19) is a systemic viral infection with known hematological impacts.
- Hematological manifestations of COVID-19 include effects on the hematopoietic system and hemostasis.
- Severe thrombocytopenia is an uncommon presentation of COVID-19.
Observation:
- This report details a rare case of immune thrombocytopenia (ITP) developing post-COVID-19 infection.
- Immune thrombocytopenia is an autoimmune disorder characterized by autoantibodies against platelet antigens.
- The patient presented with symptomatic thrombocytopenia following a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Findings:
- The occurrence of ITP following SARS-CoV-2 infection underscores rarer hematological complications of COVID-19.
- This case highlights the potential for viral infections to trigger autoimmune responses affecting platelet counts.
- Management strategies for COVID-19-associated ITP may require specific considerations.
Implications:
- Understanding these rare hematological manifestations is crucial for comprehensive patient management.
- This case may inform diagnostic approaches and treatment modifications for thrombocytopenia in COVID-19 patients.
- Further research into the immunological mechanisms linking SARS-CoV-2 and ITP is warranted.
Related Concept Videos
02:45Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
01:24Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:30Venous Thrombosis I: Introduction
13
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
13
01:25Immunodeficiency Diseases
990
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
990